NCT00380705View on ClinicalTrials.gov

Quality of Life in Asthma and Rhinitis Allergic With Singulair (0476-365)

PHASE4CompletedINTERVENTIONAL
Enrollment

91

Participants

Timeline

Start Date

March 18, 2005

Primary Completion Date

July 29, 2005

Study Completion Date

July 29, 2005

Conditions
AsthmaRhinitis Allergic
Interventions
DRUG

MK0476, Singulair, montelukast sodium / Duration of Treatment: 8 Weeks

All Listed Sponsors
lead

Organon and Co

INDUSTRY

NCT00380705 - Quality of Life in Asthma and Rhinitis Allergic With Singulair (0476-365) | Biotech Hunter | Biotech Hunter